tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (SE:ELIC)
:ELIC
Sweden Market

Elicera Therapeutics AB (ELIC) Cash flow

Compare
3 Followers

Elicera Therapeutics AB Cash Flow

SE:ELIC's free cash flow for Q3 2025 was kr-4.74M. For the 2025 fiscal year, SE:ELIC's free cash flow was decreased by kr-8.54M and operating cash flow was kr-4.74M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -23.46Mkr -14.92Mkr -8.57Mkr -14.29Mkr -905.25K
Investing Cash Flow
kr 0.00kr 483.17Kkr 0.00kr -1.00Kkr -8.88K
Financing Cash Flow
kr 20.48Mkr 0.00kr 0.00kr 55.12Mkr 12.45M
End Cash Position
kr 26.40Mkr 29.38Mkr 43.82Mkr 52.39Mkr 11.56M
Free Cash Flow
kr -23.46Mkr -14.92Mkr -8.57Mkr -14.29Mkr -964.13K
Currency in SEK

Elicera Therapeutics AB Cash Flow